Literature DB >> 17001464

Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities.

Sosipatros A Boikos1, Constantine A Stratakis.   

Abstract

First described in the mid 80's, Carney Complex (CNC) is a rare, dominantly heritable disorder with features overlapping those of McCune-Albright syndrome (MAS) and other multiple endocrine neoplasia (MEN) syndromes like MEN type 1 (MEN 1). Pituitary tumors have been described in a number of patients with CNC; they present with elevated growth hormone (GH) levels and mild hyperprolactinemia. However, most patients with CNC have mild hypersomatomammotropinemia starting in adolescence; this is similar to the situation in MAS patients: in both disorders, pituitary hyperplasia appears to precede tumor development. Familial pituitary tumor syndromes such as CNC provide an important insight into the genetics and molecular pathology of pituitary and other endocrine tumors. Our understanding of these conditions is expanding rapidly due to the identification of the causative genes and the availability of murine disease models. The present report reviews the clinical findings related to pituitary tumor development among patients with CNC and provides an update on murine models of the complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001464     DOI: 10.1007/s11102-006-0265-2

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  32 in total

Review 1.  Neurosurgical implications of Carney complex.

Authors:  J C Watson; C A Stratakis; P K Bryant-Greenwood; C A Koch; L S Kirschner; T Nguyen; J A Carney; E H Oldfield
Journal:  J Neurosurg       Date:  2000-03       Impact factor: 5.115

2.  Evidence for a second genetic locus in Carney complex.

Authors:  A D Irvine; D K Armstrong; E A Bingham; D R Hadden; N C Nevin; A E Hughes
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

3.  Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).

Authors:  S B Raff; J A Carney; D Krugman; J L Doppman; C A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2000-04       Impact factor: 1.634

4.  Pituitary pathology in Carney complex patients.

Authors:  Sotirios G Stergiopoulos; Mones S Abu-Asab; Maria Tsokos; Constantine A Stratakis
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization.

Authors:  Svetlana D Pack; Liu-Xiu Qin; Evgenia Pak; Yun Wang; David O Ault; Poonam Mannan; Sivakumar Jaikumar; Constantine A Stratakis; Edward H Oldfield; Zhengping Zhuang; Robert J Weil
Journal:  Genes Chromosomes Cancer       Date:  2005-05       Impact factor: 5.006

7.  Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity.

Authors:  J A Carney; L S Hruska; G D Beauchamp; H Gordon
Journal:  Mayo Clin Proc       Date:  1986-03       Impact factor: 7.616

8.  A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus.

Authors:  I Bossis; A Voutetakis; L Matyakhina; S Pack; M Abu-Asab; I Bourdeau; K J Griffin; N Courcoutsakis; S Stergiopoulos; D Batista; M Tsokos; C A Stratakis
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

9.  Molecular genetics of pituitary tumours.

Authors:  W E Farrell; R N Clayton
Journal:  Trends Endocrinol Metab       Date:  1998 Jan-Feb       Impact factor: 12.015

10.  Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.

Authors:  Y Shintani; K Yoshimoto; H Horie; T Sano; Y Kanesaki; E Hosoi; Y Yokogoshi; H Bando; H Iwahana; S Kannuki
Journal:  Endocr J       Date:  1995-06       Impact factor: 2.349

View more
  19 in total

Review 1.  Acromegaly in Carney complex.

Authors:  T Cuny; T T Mac; P Romanet; H Dufour; I Morange; F Albarel; A Lagarde; F Castinetti; T Graillon; M O North; A Barlier; T Brue
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

2.  Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.

Authors:  T Palumbo; F R Faucz; M Azevedo; P Xekouki; D Iliopoulos; C A Stratakis
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

3.  17p13.3 microduplication including CRK leads to overgrowth and elevated growth factors: A case report.

Authors:  Rohan K Henry; Caroline Astbury; Constantine A Stratakis; Scott E Hickey
Journal:  Eur J Med Genet       Date:  2016-09-12       Impact factor: 2.708

Review 4.  Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.

Authors:  Avital Perry; Christopher Salvatore Graffeo; Christopher Marcellino; Bruce E Pollock; Nicholas M Wetjen; Fredric B Meyer
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-24

Review 5.  Familial pituitary tumor syndromes.

Authors:  Marianne S Elston; Kerrie L McDonald; Roderick J Clifton-Bligh; Bruce G Robinson
Journal:  Nat Rev Endocrinol       Date:  2009-06-30       Impact factor: 43.330

Review 6.  Carney complex: an update.

Authors:  Ricardo Correa; Paraskevi Salpea; Constantine A Stratakis
Journal:  Eur J Endocrinol       Date:  2015-06-30       Impact factor: 6.664

7.  Post-operative growth is different in various forms of pediatric Cushing's syndrome.

Authors:  Evgenia Gourgari; Maya Lodish; Meg Keil; Robert Wesley; Suvimol Hill; Paraskevi Xekouki; Charalampos Lyssikatos; Elena Belyavskaya; Sierra Maria De La Luz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2014-09-25       Impact factor: 5.678

8.  Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Authors:  Matthew Miller; Shenglin Chen; Jeffrey Woodliff; Sanjay Kansra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 9.  Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

10.  Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  US Endocrinol       Date:  2009-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.